31Oct/13

Krissh 3: Show-stopper with heart – Yahoo India News


India Today

Krissh 3: Show-stopper with heart
Yahoo India News
At last we have India’s first truly global super-hero film. Hrithik Roshan slices through the sky skillfully weaving through the emotions and drama and adventure to create a complete entertainer. There are no concessions to vulgarity in this super-hero
Hrithik Rohsan’s Krrish 3 collects Rs 25 cr on opening dayIndian Express
Krrish 3 success brings happy Diwali for Hrithik RoshanDaily News & Analysis
Movie review: Krrish 3India Today
Hindustan Times
all 148 news articles »
31Oct/13

Early Stem Cell Transplant May Benefit Some Non-Hodgkin's Lymphoma Patients – Philly.com


Bioscience Technology

Early Stem Cell Transplant May Benefit Some Non-Hodgkin’s Lymphoma Patients
Philly.com
THURSDAY, Oct. 31 (HealthDay News) — Early stem cell transplants do not improve overall survival in high-risk patients with aggressive non-Hodgkin’s lymphoma, but may be beneficial for a small group of patients with the very highest risk, according to
Mesoporous delivery technique allows key compounds to aid stem cell transplantFierceDrugDelivery
New study evaluates early stem cell transplants for non-Hodgkin’s lymphomaMedical Xpress
Stem-Cell Therapy Misses Mark in Lymphoma TrialMedPage Today
The Oncology Report
all 16 news articles »
31Oct/13

Early Stem Cell Transplant May Benefit Some Non-Hodgkin's Lymphoma Patients – Health.com


Bioscience Technology

Early Stem Cell Transplant May Benefit Some Non-Hodgkin’s Lymphoma Patients
Health.com
THURSDAY, Oct. 31 (HealthDay News) — Early stem cell transplants do not improve overall survival in high-risk patients with aggressive non-Hodgkin’s lymphoma, but may be beneficial for a small group of patients with the very highest risk, according to
Early stem cell transplants evaluated for non-Hodgkin’s lymphoma patients at HealthCanal.com

all 16 news articles »

31Oct/13

Early Stem Cell Transplant May Benefit Some Non-Hodgkin's Lymphoma Patients – U.S. News & World Report

Early Stem Cell Transplant May Benefit Some Non-Hodgkin’s Lymphoma Patients
U.S. News & World Report
THURSDAY, Oct. 31 (HealthDay News) — Early stem cell transplants do not improve overall survival in high-risk patients with aggressive non-Hodgkin’s lymphoma, but may be beneficial for a small group of patients with the very highest risk, according to

31Oct/13

The Majority Of Oncologists Will Begin Using Biosimilar Monoclonal Antibodies … – PR Newswire (press release)

The Majority Of Oncologists Will Begin Using Biosimilar Monoclonal Antibodies
PR Newswire (press release)
EXTON, Pa., Oct. 31, 2013 /PRNewswire/ — BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed U.S. and European oncologists will cautiously adopt biosimilar 

31Oct/13

Recently released market study: Kidney Transplantation – Pipeline Review, H2 … – USPRwire (press release)

Recently released market study: Kidney Transplantation – Pipeline Review, H2
USPRwire (press release)
[USPRwire, Wed Oct 30 2013] Global Markets Direct’s, ‘Kidney Transplantation – Pipeline Review, H2 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Kidney 

and more »

31Oct/13

Fusion Antibodies supports Movember and the fight against men's cancer and … – PR Web (press release)

Fusion Antibodies supports Movember and the fight against men’s cancer and
PR Web (press release)
Fusion Antibodies Ltd has today announced a donation to support the worldwide Movember phenomenon. Starting in 2003 with just 30 people in Melbourne Australia, the Movember project now boasts over 1.1 million participants in 21 countries with funds